FFA
CC icon

Freedman Financial Associates’s Chemours CC Stock Holding History

Freedman Financial Associates’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10
Closed – – 493
2021
Q4 		$0 Hold
10
– – ﹤0.01% 468
2021
Q3 		$0 Hold
10
– – ﹤0.01% 479
2021
Q2 		$0 Hold
10
– – ﹤0.01% 473
2021
Q1 		$0 Hold
10
– – ﹤0.01% 470
2020
Q4 		$0 Buy
+10
New +$238 ﹤0.01% 466

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Freedman Financial Associates's CC Position: Q1 2022 in Review

Freedman Financial Associates sold out of Chemours (CC) in Q1 2022, closing a stake of 10 shares.

Freedman Financial Associates first reported a position in CC in Q4 2020 and held it in 5 quarters. The position peaked at $0 in Q4 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

  • Freedman Financial Associates reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 10 Chemours shares in Q1 2022.
  • Freedman Financial Associates first reported a position in Chemours in Q4 2020 and held it in 5 quarters.
  • Freedman Financial Associates's Chemours position peaked at $0 in Q4 2021.
  • 481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Freedman Financial Associates's 13F filing for Q1 2022, filed 13 Apr 2022.